Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma Article

keywords

  • ADJUVANT TEMOZOLOMIDE
  • BRAIN-TUMORS
  • HIGH-GRADE GLIOMAS
  • IN-VIVO
  • IRRADIATION
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMAS
  • MGMT PROMOTER METHYLATION
  • MULTIFORME
  • Medicine, Research & Experimental
  • RADIATION-THERAPY
  • Research & Experimental Medicine
  • Science & Technology
  • TRIAL

Digital Object Identifier (DOI)

start page

  • 410

end page

  • 413

volume

  • 76

issue

  • 3